Stuart A. Forman, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, GABA-A | 55 | 2023 | 625 | 9.750 |
Why?
|
| Etomidate | 33 | 2023 | 185 | 7.440 |
Why?
|
| Anesthetics | 22 | 2024 | 525 | 5.180 |
Why?
|
| Anesthetics, General | 18 | 2020 | 152 | 3.750 |
Why?
|
| Anesthetics, Intravenous | 12 | 2021 | 397 | 3.630 |
Why?
|
| Receptors, Nicotinic | 31 | 2014 | 494 | 2.960 |
Why?
|
| Propofol | 12 | 2023 | 608 | 2.380 |
Why?
|
| Ion Channel Gating | 21 | 2018 | 429 | 2.110 |
Why?
|
| Hypnotics and Sedatives | 12 | 2022 | 1190 | 1.980 |
Why?
|
| GABA Agonists | 11 | 2018 | 106 | 1.970 |
Why?
|
| Cysteine | 6 | 2023 | 897 | 1.830 |
Why?
|
| Protein Subunits | 12 | 2019 | 943 | 1.770 |
Why?
|
| Xenopus laevis | 30 | 2021 | 966 | 1.750 |
Why?
|
| Receptors, GABA | 6 | 2022 | 313 | 1.710 |
Why?
|
| Binding Sites | 25 | 2023 | 6023 | 1.450 |
Why?
|
| Nicotinic Antagonists | 9 | 2012 | 94 | 1.330 |
Why?
|
| GABA-A Receptor Agonists | 6 | 2014 | 86 | 1.260 |
Why?
|
| Anesthesia, General | 6 | 2020 | 1189 | 1.170 |
Why?
|
| Patch-Clamp Techniques | 22 | 2018 | 927 | 1.130 |
Why?
|
| Oocytes | 24 | 2018 | 1172 | 1.130 |
Why?
|
| gamma-Aminobutyric Acid | 20 | 2023 | 1143 | 1.090 |
Why?
|
| Locomotion | 2 | 2019 | 390 | 1.070 |
Why?
|
| Electrophysiology | 12 | 2022 | 1266 | 1.070 |
Why?
|
| Allosteric Regulation | 20 | 2020 | 424 | 1.040 |
Why?
|
| Pregnanediones | 4 | 2018 | 11 | 1.020 |
Why?
|
| Xenopus | 17 | 2020 | 711 | 0.980 |
Why?
|
| Photoaffinity Labels | 8 | 2018 | 85 | 0.950 |
Why?
|
| Anesthetics, Inhalation | 7 | 2006 | 573 | 0.890 |
Why?
|
| Ion Channels | 14 | 2010 | 1044 | 0.820 |
Why?
|
| Hypnosis | 1 | 2022 | 84 | 0.780 |
Why?
|
| Midazolam | 2 | 2022 | 267 | 0.760 |
Why?
|
| Mesylates | 1 | 2021 | 37 | 0.750 |
Why?
|
| Tryptophan | 2 | 2016 | 482 | 0.740 |
Why?
|
| Mutagenesis, Site-Directed | 9 | 2018 | 1683 | 0.710 |
Why?
|
| Genetic Techniques | 2 | 2013 | 428 | 0.700 |
Why?
|
| Glycopyrrolate | 1 | 2020 | 35 | 0.700 |
Why?
|
| Indicators and Reagents | 1 | 2021 | 455 | 0.690 |
Why?
|
| Neostigmine | 1 | 2020 | 68 | 0.680 |
Why?
|
| Larva | 9 | 2018 | 514 | 0.670 |
Why?
|
| Muscarinic Antagonists | 1 | 2020 | 136 | 0.650 |
Why?
|
| Pharmacogenetics | 2 | 2022 | 683 | 0.650 |
Why?
|
| Isoflurane | 3 | 2020 | 384 | 0.650 |
Why?
|
| Amino Acid Substitution | 5 | 2016 | 1741 | 0.640 |
Why?
|
| Reflex, Righting | 1 | 2018 | 18 | 0.630 |
Why?
|
| Barbiturates | 4 | 2022 | 113 | 0.610 |
Why?
|
| Alkanes | 3 | 2003 | 39 | 0.610 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2020 | 241 | 0.600 |
Why?
|
| Animals | 85 | 2024 | 169408 | 0.600 |
Why?
|
| Bradycardia | 1 | 2020 | 305 | 0.600 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2017 | 25 | 0.590 |
Why?
|
| Tachycardia | 1 | 2020 | 599 | 0.580 |
Why?
|
| Pentobarbital | 2 | 2016 | 153 | 0.530 |
Why?
|
| Protein Structure, Secondary | 5 | 2018 | 1216 | 0.470 |
Why?
|
| Anesthesia Department, Hospital | 1 | 2014 | 69 | 0.460 |
Why?
|
| 4-Chloromercuribenzenesulfonate | 1 | 2013 | 7 | 0.450 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2017 | 1356 | 0.440 |
Why?
|
| Ethanol | 6 | 2000 | 1332 | 0.430 |
Why?
|
| Torpedo | 17 | 2011 | 170 | 0.420 |
Why?
|
| Diazomethane | 4 | 2018 | 37 | 0.410 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 941 | 0.410 |
Why?
|
| Diazepam | 3 | 2022 | 214 | 0.380 |
Why?
|
| Cysteine Loop Ligand-Gated Ion Channel Receptors | 1 | 2011 | 4 | 0.370 |
Why?
|
| Octanols | 3 | 2007 | 25 | 0.370 |
Why?
|
| HEK293 Cells | 10 | 2020 | 4291 | 0.360 |
Why?
|
| Interleukin-2 | 1 | 2017 | 1895 | 0.360 |
Why?
|
| Mutation, Missense | 3 | 2014 | 2592 | 0.340 |
Why?
|
| Surgical Procedures, Operative | 2 | 2020 | 1941 | 0.340 |
Why?
|
| Models, Molecular | 6 | 2020 | 5404 | 0.330 |
Why?
|
| Mutation | 17 | 2023 | 30266 | 0.330 |
Why?
|
| Azirines | 3 | 2012 | 30 | 0.320 |
Why?
|
| Zebrafish | 7 | 2022 | 3037 | 0.320 |
Why?
|
| Mephobarbital | 2 | 2022 | 7 | 0.320 |
Why?
|
| Protein Structure, Tertiary | 6 | 2016 | 3775 | 0.310 |
Why?
|
| Pyrroles | 2 | 2012 | 1126 | 0.310 |
Why?
|
| Heart Rate | 1 | 2020 | 4217 | 0.300 |
Why?
|
| Biomedical Research | 2 | 2014 | 3463 | 0.300 |
Why?
|
| Killer Cells, Natural | 1 | 2017 | 2211 | 0.300 |
Why?
|
| Schools, Medical | 1 | 2014 | 882 | 0.300 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2012 | 905 | 0.290 |
Why?
|
| Dose-Response Relationship, Drug | 13 | 2020 | 10778 | 0.280 |
Why?
|
| Allosteric Site | 3 | 2014 | 105 | 0.280 |
Why?
|
| Anesthesiology | 2 | 2014 | 1137 | 0.270 |
Why?
|
| Benzodiazepines | 3 | 2021 | 1139 | 0.270 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 5505 | 0.270 |
Why?
|
| Alcohols | 5 | 1997 | 94 | 0.270 |
Why?
|
| GABA Antagonists | 2 | 2003 | 119 | 0.260 |
Why?
|
| Unconsciousness | 1 | 2008 | 251 | 0.250 |
Why?
|
| GABA Agents | 2 | 2015 | 41 | 0.250 |
Why?
|
| Structure-Activity Relationship | 12 | 2020 | 3056 | 0.250 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 2238 | 0.240 |
Why?
|
| Electrophysiological Phenomena | 2 | 2018 | 310 | 0.240 |
Why?
|
| Acetylcholine | 8 | 1999 | 629 | 0.230 |
Why?
|
| DNA, Complementary | 5 | 2009 | 1990 | 0.220 |
Why?
|
| Kinetics | 12 | 2007 | 6334 | 0.220 |
Why?
|
| Hydrocarbons, Halogenated | 1 | 2002 | 21 | 0.210 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 3724 | 0.210 |
Why?
|
| Muscles | 1 | 2007 | 1582 | 0.200 |
Why?
|
| Consciousness | 1 | 2008 | 602 | 0.200 |
Why?
|
| Humans | 61 | 2024 | 768887 | 0.200 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2018 | 1339 | 0.190 |
Why?
|
| Cell Line | 7 | 2017 | 15603 | 0.190 |
Why?
|
| 1-Butanol | 1 | 2001 | 13 | 0.190 |
Why?
|
| Flumazenil | 4 | 2021 | 84 | 0.190 |
Why?
|
| Hexanols | 1 | 2000 | 6 | 0.190 |
Why?
|
| Photic Stimulation | 1 | 2008 | 2003 | 0.190 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 3 | 2010 | 45 | 0.180 |
Why?
|
| Animals, Genetically Modified | 2 | 2019 | 1564 | 0.180 |
Why?
|
| Blood Proteins | 1 | 2006 | 1191 | 0.180 |
Why?
|
| Membrane Potentials | 5 | 2015 | 1090 | 0.180 |
Why?
|
| Female | 31 | 2021 | 397464 | 0.180 |
Why?
|
| Protein Binding | 6 | 2014 | 9344 | 0.180 |
Why?
|
| Plasmids | 3 | 2012 | 2269 | 0.180 |
Why?
|
| Adrenal Cortex | 2 | 2011 | 134 | 0.180 |
Why?
|
| Ligands | 10 | 2017 | 3283 | 0.170 |
Why?
|
| Amnesia | 1 | 2022 | 258 | 0.170 |
Why?
|
| Affinity Labels | 1 | 1999 | 107 | 0.170 |
Why?
|
| Central Nervous System Depressants | 1 | 2000 | 164 | 0.170 |
Why?
|
| Models, Biological | 5 | 2012 | 9499 | 0.160 |
Why?
|
| Nicotinic Agonists | 3 | 2014 | 266 | 0.160 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2012 | 395 | 0.150 |
Why?
|
| Rats | 6 | 2018 | 23847 | 0.150 |
Why?
|
| Mice, Knockout | 4 | 2019 | 14485 | 0.150 |
Why?
|
| Synapses | 3 | 2017 | 1766 | 0.150 |
Why?
|
| Conscious Sedation | 1 | 2022 | 534 | 0.140 |
Why?
|
| Caenorhabditis elegans | 1 | 2006 | 1469 | 0.140 |
Why?
|
| Cattle | 5 | 2012 | 3820 | 0.140 |
Why?
|
| Receptors, Cholinergic | 2 | 1989 | 244 | 0.140 |
Why?
|
| Amino Acid Sequence | 6 | 2014 | 13427 | 0.140 |
Why?
|
| Molecular Sequence Data | 7 | 2014 | 17629 | 0.140 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 378 | 0.130 |
Why?
|
| Light | 3 | 2012 | 1356 | 0.130 |
Why?
|
| Mice | 16 | 2019 | 82074 | 0.130 |
Why?
|
| Central Nervous System | 1 | 2003 | 1345 | 0.130 |
Why?
|
| Convulsants | 1 | 2015 | 70 | 0.130 |
Why?
|
| Metabolomics | 1 | 2024 | 1675 | 0.120 |
Why?
|
| Brain | 6 | 2014 | 27476 | 0.120 |
Why?
|
| Phenobarbital | 1 | 2015 | 192 | 0.120 |
Why?
|
| Neurotransmitter Agents | 1 | 2018 | 665 | 0.120 |
Why?
|
| Boston | 2 | 2020 | 9375 | 0.120 |
Why?
|
| Cell Membrane | 5 | 2014 | 3659 | 0.120 |
Why?
|
| Drug Partial Agonism | 1 | 2014 | 24 | 0.110 |
Why?
|
| Reflex | 3 | 2011 | 375 | 0.110 |
Why?
|
| Coculture Techniques | 1 | 2017 | 1342 | 0.110 |
Why?
|
| Carbachol | 5 | 1993 | 223 | 0.110 |
Why?
|
| Recombinant Proteins | 4 | 2015 | 6512 | 0.110 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 1839 | 0.110 |
Why?
|
| Death, Sudden | 1 | 2015 | 301 | 0.100 |
Why?
|
| Pulmonary Ventilation | 1 | 2015 | 375 | 0.100 |
Why?
|
| GABA-A Receptor Antagonists | 2 | 2003 | 59 | 0.100 |
Why?
|
| GABA Modulators | 2 | 2020 | 109 | 0.100 |
Why?
|
| Point Mutation | 1 | 2018 | 1595 | 0.100 |
Why?
|
| Erythrocyte Membrane | 2 | 1985 | 438 | 0.100 |
Why?
|
| Transfection | 4 | 2010 | 5763 | 0.100 |
Why?
|
| Molecular Structure | 4 | 2020 | 1885 | 0.100 |
Why?
|
| Azo Compounds | 1 | 2012 | 116 | 0.100 |
Why?
|
| Mice, SCID | 1 | 2017 | 2631 | 0.100 |
Why?
|
| Synaptic Membranes | 3 | 1991 | 89 | 0.100 |
Why?
|
| Carboxylic Acids | 1 | 2011 | 91 | 0.090 |
Why?
|
| Faculty | 1 | 2014 | 383 | 0.090 |
Why?
|
| Feasibility Studies | 1 | 2022 | 5323 | 0.090 |
Why?
|
| Plant Oils | 1 | 2012 | 199 | 0.090 |
Why?
|
| Fluoxetine | 1 | 2015 | 735 | 0.090 |
Why?
|
| Microelectrodes | 2 | 2003 | 308 | 0.090 |
Why?
|
| Receptors, Adrenergic | 1 | 2011 | 155 | 0.090 |
Why?
|
| Proteomics | 1 | 2024 | 3913 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2018 | 8200 | 0.090 |
Why?
|
| Anesthesia, Intravenous | 1 | 2011 | 130 | 0.090 |
Why?
|
| Epilepsy | 2 | 2015 | 3326 | 0.090 |
Why?
|
| Cell Division | 1 | 2017 | 4478 | 0.090 |
Why?
|
| Tetracycline | 1 | 2010 | 216 | 0.080 |
Why?
|
| Adrenal Cortex Diseases | 1 | 2009 | 13 | 0.080 |
Why?
|
| Chemistry, Physical | 2 | 2002 | 153 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2006 | 7885 | 0.080 |
Why?
|
| Solubility | 4 | 2012 | 1087 | 0.080 |
Why?
|
| Chemical Phenomena | 2 | 2002 | 486 | 0.080 |
Why?
|
| RNA, Messenger | 3 | 2014 | 12809 | 0.080 |
Why?
|
| Pulmonary Alveoli | 2 | 2003 | 665 | 0.080 |
Why?
|
| Procaine | 1 | 1989 | 60 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3621 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2017 | 3744 | 0.080 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins | 1 | 2008 | 7 | 0.080 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIc | 1 | 2008 | 14 | 0.080 |
Why?
|
| Drug Design | 2 | 2010 | 1046 | 0.080 |
Why?
|
| Shaw Potassium Channels | 1 | 2008 | 20 | 0.080 |
Why?
|
| Hypercalciuria | 1 | 2008 | 31 | 0.080 |
Why?
|
| Rubidium | 6 | 1993 | 121 | 0.080 |
Why?
|
| Membranes | 3 | 2001 | 164 | 0.070 |
Why?
|
| Threonine | 1 | 2008 | 273 | 0.070 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2017 | 1519 | 0.070 |
Why?
|
| Chloride Channels | 1 | 2008 | 222 | 0.070 |
Why?
|
| Models, Animal | 2 | 2020 | 2123 | 0.070 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 9564 | 0.070 |
Why?
|
| Binding, Competitive | 3 | 2020 | 1142 | 0.070 |
Why?
|
| Algorithms | 5 | 2009 | 14199 | 0.070 |
Why?
|
| Microinjections | 1 | 2007 | 323 | 0.070 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2007 | 466 | 0.070 |
Why?
|
| Stereoisomerism | 5 | 2012 | 612 | 0.070 |
Why?
|
| Photochemical Processes | 2 | 2020 | 85 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2014 | 2771 | 0.070 |
Why?
|
| Benzophenones | 1 | 2006 | 57 | 0.070 |
Why?
|
| Iatrogenic Disease | 1 | 2010 | 552 | 0.070 |
Why?
|
| Electric Organ | 4 | 1999 | 55 | 0.070 |
Why?
|
| Respiratory Insufficiency | 1 | 2015 | 1241 | 0.070 |
Why?
|
| Hemodynamics | 3 | 2011 | 4199 | 0.060 |
Why?
|
| Steroids | 1 | 2011 | 938 | 0.060 |
Why?
|
| Anticonvulsants | 1 | 2015 | 1924 | 0.060 |
Why?
|
| Halothane | 1 | 1985 | 200 | 0.060 |
Why?
|
| Choline | 1 | 1987 | 522 | 0.060 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 1 | 1985 | 150 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2011 | 1893 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2008 | 1762 | 0.060 |
Why?
|
| Ultraviolet Rays | 2 | 2007 | 1104 | 0.060 |
Why?
|
| Neuroprotective Agents | 1 | 2010 | 958 | 0.060 |
Why?
|
| Registries | 1 | 2020 | 8384 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2008 | 1207 | 0.050 |
Why?
|
| Butanes | 1 | 2003 | 5 | 0.050 |
Why?
|
| Phloretin | 1 | 1982 | 16 | 0.050 |
Why?
|
| Carbolines | 1 | 2005 | 296 | 0.050 |
Why?
|
| Picrotoxin | 1 | 2002 | 61 | 0.050 |
Why?
|
| Gene Expression | 2 | 2018 | 7602 | 0.050 |
Why?
|
| Serotonin | 1 | 2007 | 1045 | 0.050 |
Why?
|
| Drug Discovery | 1 | 2010 | 1068 | 0.050 |
Why?
|
| Drug Interactions | 2 | 2007 | 1421 | 0.050 |
Why?
|
| Neurons | 3 | 2014 | 9524 | 0.050 |
Why?
|
| Brain Chemistry | 1 | 2005 | 962 | 0.050 |
Why?
|
| Electroencephalography | 2 | 2008 | 6318 | 0.050 |
Why?
|
| Cyclopropanes | 1 | 2003 | 437 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 4415 | 0.050 |
Why?
|
| Drug Antagonism | 1 | 2020 | 50 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 1985 | 4940 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 17174 | 0.040 |
Why?
|
| Biotransformation | 2 | 2011 | 166 | 0.040 |
Why?
|
| Dopamine | 1 | 2007 | 1617 | 0.040 |
Why?
|
| Ion Transport | 1 | 2001 | 322 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 2714 | 0.040 |
Why?
|
| Isomerism | 2 | 2015 | 198 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 4980 | 0.040 |
Why?
|
| Time Factors | 2 | 2020 | 40266 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2008 | 2179 | 0.040 |
Why?
|
| Male | 7 | 2020 | 365249 | 0.040 |
Why?
|
| Amino Acids | 2 | 2005 | 1716 | 0.040 |
Why?
|
| Anesthesia | 1 | 2010 | 1596 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 24330 | 0.040 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2020 | 452 | 0.040 |
Why?
|
| DNA | 1 | 2012 | 7214 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2012 | 5107 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2005 | 3956 | 0.030 |
Why?
|
| Receptors, Parathyroid Hormone | 1 | 1998 | 332 | 0.030 |
Why?
|
| Imidazoles | 1 | 2003 | 1169 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2001 | 19023 | 0.030 |
Why?
|
| Postural Balance | 2 | 2010 | 639 | 0.030 |
Why?
|
| Serum Albumin | 1 | 1998 | 677 | 0.030 |
Why?
|
| Ketamine | 1 | 2020 | 527 | 0.030 |
Why?
|
| Risk Factors | 2 | 2020 | 74971 | 0.030 |
Why?
|
| Muscimol | 1 | 2013 | 70 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2015 | 624 | 0.030 |
Why?
|
| Rubidium Radioisotopes | 2 | 1993 | 97 | 0.030 |
Why?
|
| Anion Transport Proteins | 2 | 1985 | 141 | 0.030 |
Why?
|
| Xenopus Proteins | 1 | 2016 | 435 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 65485 | 0.030 |
Why?
|
| Erythrocytes | 1 | 1982 | 2421 | 0.030 |
Why?
|
| Hydrocortisone | 2 | 2011 | 1842 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 7472 | 0.020 |
Why?
|
| Kidney | 2 | 2008 | 7057 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2020 | 81892 | 0.020 |
Why?
|
| Serotonin 5-HT3 Receptor Antagonists | 1 | 2010 | 23 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 2010 | 367 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2003 | 3590 | 0.020 |
Why?
|
| Esterases | 1 | 2009 | 89 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2010 | 525 | 0.020 |
Why?
|
| Computer Simulation | 2 | 2016 | 6289 | 0.020 |
Why?
|
| Bungarotoxins | 1 | 1988 | 47 | 0.020 |
Why?
|
| Tritium | 1 | 2009 | 707 | 0.020 |
Why?
|
| Opossums | 1 | 2008 | 104 | 0.020 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2010 | 161 | 0.020 |
Why?
|
| Neoplasms | 1 | 2017 | 22390 | 0.020 |
Why?
|
| Half-Life | 1 | 2009 | 651 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2012 | 1751 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2010 | 8758 | 0.020 |
Why?
|
| Action Potentials | 1 | 2015 | 1838 | 0.020 |
Why?
|
| Isoflurophate | 1 | 1987 | 27 | 0.020 |
Why?
|
| Mathematics | 1 | 1989 | 704 | 0.020 |
Why?
|
| Aged | 2 | 2020 | 171790 | 0.020 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 1987 | 161 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2010 | 15889 | 0.020 |
Why?
|
| Adult | 2 | 2020 | 223818 | 0.020 |
Why?
|
| Exocytosis | 1 | 2008 | 323 | 0.020 |
Why?
|
| Models, Theoretical | 2 | 1989 | 3580 | 0.020 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 1987 | 204 | 0.020 |
Why?
|
| Cricetulus | 1 | 2008 | 813 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2007 | 867 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 1995 | 2053 | 0.020 |
Why?
|
| Middle Aged | 2 | 2020 | 223740 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2007 | 877 | 0.020 |
Why?
|
| Lidocaine | 1 | 2009 | 546 | 0.020 |
Why?
|
| CHO Cells | 1 | 2008 | 1380 | 0.020 |
Why?
|
| Aziridines | 1 | 2005 | 23 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2010 | 4168 | 0.020 |
Why?
|
| Cricetinae | 1 | 2008 | 2423 | 0.010 |
Why?
|
| Phosphates | 1 | 2008 | 765 | 0.010 |
Why?
|
| Serine | 1 | 2008 | 831 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 18366 | 0.010 |
Why?
|
| 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 1 | 1982 | 33 | 0.010 |
Why?
|
| Sodium | 1 | 2008 | 1597 | 0.010 |
Why?
|
| Alleles | 2 | 2008 | 6901 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2007 | 1743 | 0.010 |
Why?
|
| Nicotine | 1 | 1987 | 681 | 0.010 |
Why?
|
| Haplotypes | 1 | 2008 | 2725 | 0.010 |
Why?
|
| Reaction Time | 1 | 2007 | 2102 | 0.010 |
Why?
|
| Stroke Volume | 1 | 1995 | 5621 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 2005 | 1034 | 0.010 |
Why?
|
| Biological Transport | 1 | 1985 | 2085 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1995 | 14751 | 0.010 |
Why?
|
| Rana pipiens | 1 | 1999 | 64 | 0.010 |
Why?
|
| Cerebral Cortex | 2 | 2010 | 5834 | 0.010 |
Why?
|
| Aging | 1 | 1998 | 8765 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1982 | 2488 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2008 | 8317 | 0.010 |
Why?
|
| Base Sequence | 1 | 2008 | 12430 | 0.010 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 1 | 1998 | 305 | 0.010 |
Why?
|
| COS Cells | 1 | 1998 | 1135 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2010 | 3985 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 1998 | 910 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1982 | 1933 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 1995 | 11521 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1998 | 1904 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 2749 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1993 | 305 | 0.010 |
Why?
|
| Disease Progression | 1 | 2010 | 13677 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1995 | 1998 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2008 | 16051 | 0.000 |
Why?
|
| Survival Analysis | 1 | 1995 | 10115 | 0.000 |
Why?
|
| Heart | 1 | 1995 | 4448 | 0.000 |
Why?
|
| Exercise | 1 | 1995 | 5953 | 0.000 |
Why?
|
| Prognosis | 1 | 1995 | 30044 | 0.000 |
Why?
|